James Yang Liu

CIK: 0001944774

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (20.0%)

Derivative conversions

Awards (A)3 (60.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (20.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

IMDX

Insight Molecular Diagnostics Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (5 total)

IMDX
Insight Molecular Diagnostics Inc.
Mar 26, 2026
Exercise(M)
Direct
6.3K shares-
IMDX
Insight Molecular Diagnostics Inc.
Mar 26, 2026
Tax Payment(F)
Direct
2.6K shares at avg. $4.11$11K
IMDX
Insight Molecular Diagnostics Inc.
Sep 28, 2025
Award(A)
Option to Purchase Common Stock
Direct
18K shares-
OCX
Oncocyte Corp
Mar 26, 2025
Award(A)
Option to Purchase Common Stock
Direct
10K shares-
OCX
Oncocyte Corp
Mar 26, 2025
Award(A)
Restricted Stock Units
Direct
18.9K shares-

		Type	Shares	Price		Ownership
Mar 26, 2026	IMDX Insight Molecular Diagnostics Inc.	Exercise(M)	6,289	-	$0	Direct
Mar 26, 2026	IMDX Insight Molecular Diagnostics Inc.	Tax Payment(F)	2,578	$4.11	$10,596	Direct
Sep 28, 2025	IMDX Insight Molecular Diagnostics Inc.	Award(A) Option to Purchase Common Stock	18,000	-	-	Direct
Mar 26, 2025	OCX Oncocyte Corp	Award(A) Option to Purchase Common Stock	10,000	-	-	Direct
Mar 26, 2025	OCX Oncocyte Corp	Award(A) Restricted Stock Units	18,867	-	-	Direct

1-5 of 5 transactions

About Liu James Yang

Liu James Yang (SEC CIK 0001944774) files insider reports with the SEC as VP ACCT, Cntlr, Treasurer, PAO of Insight Molecular Diagnostics Inc. (IMDX).

Signal8 holds 3 ownership filings by Liu James Yang, all Form 4s, filed between Mar 28, 2025 and Mar 30, 2026. Those filings report 5 transactions, from Mar 26, 2025 to Mar 26, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Liu James Yang's filings is in NASHVILLE, TN.

Recent filings by Liu James Yang

Mar 26, 2026: Option exercise of IMDX shares (Form 4, code M).
Mar 26, 2026: Tax withholding of IMDX shares (Form 4, code F).
Sep 28, 2025: Grant or award of IMDX derivative securities (Form 4, code A).
Mar 26, 2025: Grants or awards of OCX derivative securities (2 lines, Form 4, code A).

Other insiders filing for Insight Molecular Diagnostics Inc. (IMDX)

SILVERMAN LOU, Director
Last Andrew J., Director
Arno Andrew, Director
BROADWOOD PARTNERS, L.P., 10% Owner
James Andrea S., Chief Financial Officer
Riggs Josh, CEO and President

How to read Form 4 transaction codes